"Swine flu is a reality and infected over 60 million people world wide last time 2009, sars Corona 2002 not many in comparison, swine flu about to make a comeback like SARS did with corona 19 and we have the phase 1 already done, this is a plateform Technology iikey, it’s a stand alone company, we need more work other then a merck partnered breast cancer trial, corona opened the door to dust off infectious disease, swine flu gives us another area in infectious disease, it’s good to see ngio now is not just a one trick pony with breast and a licensed prostate trial, need atleast a few more to make ngio a real company on Nasdaq - and since we are the only one with good phase one data with swine it will keep the company busy with real world problems with a plateform that can respond quickly, now we just need the money to do these hot areas, let’s hope the sec finally approves these s1’s..."
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links